Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in its Phase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback